Takeda Pharmaceutical Co Ltd - Jan 24, 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
10%+ Owner
Signature
/s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Stock symbol
PHAT
Transactions as of
Jan 24, 2024
Transactions value $
-$29,999,994
Form type
4
Date filed
1/25/2024, 06:13 AM
Previous filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$30M -3.7M -49.65% $8.10 3.76M Jan 24, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Takeda Pharmaceutical Co Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.